Portfolio Companies

Tools:

Alpha Innotech, , Biocompare, Epitomics, Fermentas, Panomics, SuperArray, System Biosciences

Drug Development:

BioKey, Optimer Pharmaceuticals, Pepgen, StemCyte

Diagnostics:

Diagcor, Diagnostic Hybrids (DHI)

Medical Devices

BioForm

Other:

DailyWellness

 

Alpha Innotech
www.alphainnotech.com
San Leandro, California
Alpha Innotech is providing complete imaging solutions for the genetic research and drug discovery markets.  The company was acquired by Cell Biosciences in Santa Clara, California in October 2009.

Biocompare, Inc.
www.biocompare.com
Burlingame, California
Biocompare, Inc. is an internet-based company that provides advertisements for life science and biomedical products (see www.medcompare.com).

BioForm Mediacl, Inc.
www.bioform.com
San Mateo, California
BioForm Medical, Inc. (NASDAQ: BFRM) is a medical device company developing and commercializing a family of proprietary injectable implant products for the treatment of certain illness as well as for the use in cosmetic tissue augmentation.  The company went public in November 2007.

BioKey, Inc.
www.biokeyinc.com
Fremont, California
BioKey is using controlled release platform technologies to develop and market generic drugs and accelerated new drug application (NDA) products.

Daily Wellness
www.dailywellness.com
Mountain View, California
Daily Wellness is a provider of human health supplement technology and products.  Fertility blend and Argimax are the major products.

DiagCor Bioscience Inc. Limited
www.diagcor.com
Hong Kong, PRC
Diagcor develops and commercializes in vitro diagnostic kits and instrucmentations using company's proprietary platform technology.  Moreover, DiagCor utilizes its forefront expertise to build the genomic testing diagnostic service network in Mainland China and Asia Pacific Region.

Diagnostic Hybrids, Inc.
www.dhiusa.com
Athens, Ohio
Diagnostic Hybrids develops, manufactures, and markets diagnostic cell cultures and virus detection kit systems used in the clinical diagnosis of infectious and autoimmune diseases.  The company was acquired by Quidel (NASDAQ: QDEL) in January 2010.

Epitomics, Inc.
www.epitomics.com
South San Francisco, California
Epitomics, Inc., an emerging biotechnology company, is dedicated to developing proprietary Rabbit  monoclonal antibody technology (MAb) to the research and the therapeutic markets.  Its Rabbit monoclonal technology is considered the pioneer in the monoclonal antibody area and is becoming increasingly popular among end-users.

Fermentas, Inc.
www.fermentas.com
Burlington, Onterio, Canada
Fermentas is a leader in the discovery, manufacturing, and marketing of high quality molecular biology products for life sciences research community worldwide. Product offerings include FastDigest restriction enzymes, DNA/RNA modifying enzymes, DNA/protein purification kits, reagents for use in PCR, cloning, and sequencing, etc.  The company was acquired by Thermo Fisher Scientific (NYSE: TMO) in May 2010.

Optimer
www.optimerpharma.com
San Diego, California
Optimer (NASDAQ: OPTR) is developing novel carbohydrate chemistry to attack antibiotics-resistant bacteria.  Currently, the company has 2 proprietary antibiotics under late stage of clinical trials.  The company went public in February 2007.

Panomics
www.panomics.com
Fremont, California
Panomics is developing and marketing novel and innovative tools for the molecular and cell biology research fields.  Panomics has merged with Genospectra in 2006 forming a new entity.  The new company currently operates under the name Panomics. The new company was acquired by Affymetrix (NASDAQ: Affx) in December 2008.

Pepgen Corporation
www.pepgen.com
Alameda, California
Pepgen develops a novel form of interferon for the treatment of a wide range of human diseases including multiple sclerosis, cancer, and viral infections.

StemCyte
www.stemcyte.com
Acadia, California
StemCyte specializes in cord blood stem cell technology including transplantation therapy, diagnostics, and research.

SuperArray
www.superarray.com
Frederick, Maryland
SuperArray, Inc. is a fast-growing company dedicated to providing life scientists and biomedical researchers with cutting edge array technology and a number of innovative research tools to advance functional studies. The company was acquired by Qiagen (NASDAQ: QGEN) in December 2009.

System Biosciences
www.systembio.com
Mountain View, California
System Biosciences focuses on developing unique and proprietary siRNA and microRNA technologies that provide life science researchers with tools to investigate gene functions.

Home | Company | News | Investment | Portfolio | Contact